Liver injury following administration of 8-methoxypsoralen during PUVA therapy.

A case of liver injury caused by 8-methoxypsoralen given orally during PUVA therapy is presented. The reaction, manifested by elevated serum alanine-aminotransferase and serum aspartate-aminotransferase, was provoked on three consecutive occasions, on the last one with 8-MOP only. The liver injury seems to be of the hepatocellular and nonpredictable type.

• Publication year

  1979

• Venue

  Acta Dermato-Venereologica

• Publication date

  1979-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2340/0001555559371372PMID 92158
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating immune complexes after repeated halothane anaesthesia.

  1977cited by this paper
• Photochemotherapy for psoriasis with orally administered methoxsalen.

  1976cited by this paper
• Treatment of psoriasis with oral psoralens and longwave ultraviolet light. Therapeutic results and cytogenetic hazards.

  1975cited by this paper
• Effect of imperatorin, a toxic principle from Ammi majus, on energy-transfer in mitochondria.

  1968cited by this paper

• Molecular mechanisms of hepatotoxicity induced by compounds occurring in Evodiae Fructus

  2023cites this paper
• Differences in xanthotoxin metabolites in seven mammalian liver microsomes.

  2020cites this paper
• Adaptive homeostasis of the vitamin D–vitamin D nuclear receptor axis in 8‐methoxypsoralen‐induced hepatotoxicity

  2019cites this paper
• University of Dundee British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015

  2017cites this paper
• 8-Methoxypsoralen disrupts MDR3-mediated phospholipids efflux and bile acid homeostasis and its relevance to hepatotoxicity.

  2017cites this paper
• British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen–ultraviolet A therapy 2015

  2016cites this paper
• Treatment of psoriasis in patients with hepatitis C: from the Medical Board of the National Psoriasis Foundation.

  2009cites this paper
• Efectos adversos de la fototerapia: clínica y manejo

  2008cites this paper
• [Consensus document on phototherapy: PUVA therapy and narrow-band UVB therapy].

  2005cites this paper
• Documento de consenso sobre fototerapia: terapias PUVA y UVB de banda estrecha

  2005cites this paper
• PHOTOTHERAPY (UVB) AND PHOTOCHEMOTHERAPY (PUVA) FOR PSORIASIS

  2002cites this paper
• Hepatitis from 5‐methoxypsoralen occurring in a patient with previous flucloxacillin hepatitis

  1999cites this paper
• Traditional Remedies and Food Supplements

  1997cites this paper
• Reproducible elevation of liver transaminases by topical 8-methoxypsoralen.

  1994cites this paper
• Severe hyperlipidemia following treatment with PUVA for acute skin GVHD.

  1994cites this paper
• British Photodermatology Group guidelines for PUVA.

  1994cites this paper
• British Photodermatology Group guidelines for PUVA

  1994cites this paper
• Fulminant hepatic failure after methotrexate and PUVA therapy for psoriasis.

  1993cites this paper
• The effect on liver transaminases of phototoxic drugs used in systemic photochemotherapy.

  1992cites this paper
• Unusual immediate adverse effects of photochemotherapy

  1990cites this paper
• [Experience in the photochemotherapy of psoriasis with rectal administration of the photosensitizer].

  1989cites this paper
• Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients.

  1988cites this paper
• Psoralens and related compounds in the treatment of psoriasis.

  1987cites this paper
• Psoralen photochemotherapy.

  1987cites this paper
• [Chronic systemic toxicity of oral photochemotherapy using 8-methoxypsoralen and UVA].

  1987cites this paper
• Inactivation and induction of cytochrome P-450 by various psoralen derivatives in rats.

  1986cites this paper
• Inactivation of cytochrome P-450 by the drug methoxsalen.

  1986cites this paper
• Liver biopsies from patients with psoriasis related to photochemotherapy (PUVA): findings before and after 1 year of therapy in twelve patients. A blind study and review of literature on hepatotoxicity of PUVA.

  1986cites this paper
• Acute methoxsalen intoxication.

  1986cites this paper
• [Hepatitis due to etretinate].

  1985cites this paper
• [Alpha 1-fetoprotein--a marker of potential PUVA side-effects in psoriasis?].

  1985cites this paper
• THE PHOTOCHEMICAL INTERACTION BETWEEN THE TRIPLET STATE OF 8‐METHOXYPSORALEN AND THE MELANIN PRECURSORL–3, 4 DIHYDROXYPHENYLALANINE

  1984cites this paper
• Observations on PUVA treatment of psoriasis and on 5-S-cysteinyldopa after exposure to UV light.

  1983cites this paper
• The Science of Photomedicine

  1982cites this paper
• Photochemotherapy of Skin Diseases

  1982cites this paper
• Distribution of 3H-8-MOP and its metabolites in rat organs after a single oral administration.

  1981cites this paper
• Toxic hepatitis after PUVA.

  1981cites this paper
• Clinical aspects of photochemotherapy.

  1981cites this paper
• Dermatologic therapy: December, 1978, through November, 1979.

  1980cites this paper
• Drug effects on the liver

  1979cites this paper